Allergan Sustainability Performance Reports
Allergan has been tracking sustainability performance for since 1992 and made significant progress toward improving our performance. Below is a summary of five key sustainability performance indicators. Details on additional indicators are included in our Allergan Sustainability Performance Report.
Safety Performance Trend
Allergan continues our top quartile safety performance as measured by the number of injuries/illness requiring treatment beyond first aid. In 2013, we achieved an incident rate of 0.57 incidents per 100 employees. This is Allergan’s lowest incident rate on record. We also managed the number of more severe incidents as measured by the number of incidents requiring days away from work.
Climate Change and GHG Trends
The 2013 overall GHG profile for Allergan are presented in the following figures. Scope 1 GHG emissions refer to the direct GHG emissions resulting primarily from combustion processes. Scope 2 GHG emissions refer to GHG emissions resulting primarily from the consumption of purchased electricity. GHG emissions increased by 1% vs. 2012 even with the addition of the new business acquisitions and existing facility expansions. These acquisitions have significantly changed Allergan’s carbon footprint on an absolute basis. Allergan would have been at pre-1998 levels if the recent acquisitions were not included. Projects to reduce energy consumption and consequently Allergan’s GHG emissions at these new facilities are already underway.
Energy Consumption Trend
In 2013 versus 2012, energy consumption decreased by 2.3% on an absolute basis when the data is rebaselined for acquisition and existing facility expansion. Allergan has used tools such as Lean 6 Sigma, DMAIC, metering and sub-metering, and Energy Star performance indicators to ensure that energy efficiency is maintained. The acquisitions and existing facility expansions have several energy efficiency opportunities being implemented.
Waste Generation Performance Trend
On an absolute basis, the hazardous waste decreased by 12% in 2013 vs. 2012 even with increasing production rates. Allergan realized a 10% increase in nonhazardous waste sent for disposal in 2013 vs. 2012. The waste generated per production unit decreased by 5% in 2013 vs. 2012. The waste generated per sales units increased 5% in 2013 vs. 2012. Allergan has set aggressive targets of 15% hazardous and nonhazardous waste reduction based on 2010 levels to be achieved by 2015.
Allergan increased its recycling rate from 29% in 1995 to 76% in 2013. The goal in 2013 was to maintain the recycling rate greater than 75%, and the result was 76%. The target for the strategic plan expected to be reached by 2015 is 75%. Notable recycling rate improvements occurred at Allergan Medical Heredia Costa Rica and Allergan Medical Santa Barbara. Allergan Pharmaceuticals Westport and Allergan Medical Pringy are still leading with the highest recycling rates at 100%.